Clinical trials

  • ABEMACICLIB for Early-stage breast cancer (hormone receptor-positive, HER2-negative)
  • LY3484356 for Breast cancer|Endometrial cancer
  • Clinical trial in Metastatic neuroendocrine prostate cancer
  • SELPERCATINIB for Medullary thyroid cancer (RET‑mutant)
  • MAVACAMTEN for Symptomatic Obstructive Hypertrophic Cardiomyopathy|Hypertrophic obstructive cardiomyopathy
  • Human IgG1 monoclonal antibody against sialyl-Lewis A for Pancreatic ductal adenocarcinoma (resected, R0/R1)
  • ZASOCITINIB for Crohn's disease | Moderately to severely active Crohn's disease
  • BMS-986453 for Relapsed/refractory multiple myeloma
  • TOFERSEN for Amyotrophic lateral sclerosis (SOD1-associated)
  • Rabbit anti-human thymocyte immunoglobulin for Haematological malignancies
  • HMB-001 for Glanzmann Thrombasthenia|Glanzmann's disease
  • LITIFILIMAB for Systemic lupus erythematosus